Abstract
Background
Although chronic postsurgical pain (CPSP) after breast cancer surgery is a common and prevalent postsurgical adverse event, the need for CPSP treatment has not been investigated. This study examined the proportion of patients who needed treatment for CPSP and associated predictors.
Methods
We conducted a cross-sectional study with female patients who underwent breast cancer surgery at our institution. Participants were aged ≤ 65 years at the time of this study and were at least 1 year post surgery. The questionnaire examined the presence of and need for treatment for CPSP and included the Japanese version of the Concerns about Recurrence Scale (CARS-J). Multivariate analyses were used to identify independent predictors of needing treatment for CPSP.
Results
In total, 305 patients completed the questionnaire. The mean time since surgery was 67.1 months; 156 (51%) patients developed CPSP after breast cancer surgery and 61 (39%) needed treatment for CPSP. Among patients that developed CPSP, the fear of breast cancer recurrence as assessed by the CARS-J (odds ratio [OR] 2.59, 95% confidence interval [CI] 1.14–6.28, P = 0.028) and ≥ 2 postsurgical pain regions (OR 2.52, 95% CI 1.16–5.57, P = 0.020) were independent predictors of needing treatment for CPSP.
Conclusions
This study is the first to identify the proportion and predictors of patients who need treatment for CPSP. Fear of breast cancer recurrence and ≥ 2 postsurgical pain regions may predict the need for CPSP treatment among patients following breast cancer surgery.
Similar content being viewed by others
Availability of data and materials
The datasets analyzed during the present study are available from the corresponding author on reasonable request.
References
Sharma R. Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990–2016: evidence from Global Burden of Disease Study 2016. Breast Cancer. 2019;26:428–45.
Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, et al. Annual report to the Nation on the Status of Cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Instit. 2015;107:djv048.
de Gelder R, Heijnsdijk EAM, Fracheboud J, Draisma G, de Koning HJ. The effects of population-based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy. Int J Cancer. 2015;137:165–72.
Mehdi S, Abbas H, Al A, Hosein M, Khadije R, Keikhaie R. Health-related quality of life of breast cancer patients in the Eastern Mediterranean region: a systematic review and meta-analysis. Breast Cancer Res Treat. 2019;174:585–96. https://doi.org/10.1007/s10549-019-05131-0.
Andersen KG, Duriaud HM, Jensen HE, Kroman N, Kehlet H. Predictive factors for the development of persistent pain after breast cancer surgery. Pain. 2015;156:2413–22.
Okamoto A, Yamasaki M, Yokota I, Mori M, Matsuda M, Yamaguchi Y, et al. Classification of acute pain trajectory after breast cancer surgery identifies patients at risk for persistent pain: a prospective observational study. J Pain Res. 2018;11:2197–206.
Wang L, Cohen JC, Devasenapathy N, Hong BY, Kheyson S, Lu D, et al. Prevalence and intensity of persistent post-surgical pain following breast cancer surgery: a systematic review and meta-analysis of observational studies. Br J Anaesth. 2020;125:346–57. https://doi.org/10.1016/j.bja.2020.04.088.
Mejdahl MK, Andersen KG, Gärtner R, Kroman N, Kehlet H. Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study. BMJ. 2013;346:f1865.
Burckhardt CS, Jones KD. Effects of chronic widespread pain on the health status and quality of life of women after breast cancer surgery. Health Qual Life Outcome. 2005;3:30.
Marschner N, Trarbach T, Rauh J, Meyer D, Müller S, Johanna H, et al. Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project. Breast Cancer Res Treat. 2019;175:701–12. https://doi.org/10.1007/s10549-019-05197-w.
Hamood R, Hamood H, Merhasin I, Keinan-Boker L. Chronic pain and other symptoms among breast cancer survivors: prevalence, predictors, and effects on quality of life. Breast Cancer Res Treat. 2018;167:157–69.
Akechi T, Okuyama T, Endo C, Sagawa R, Uchida M, Nakaguchi T, et al. Patient’s perceived need and psychological distress and/or quality of life in ambulatory breast cancer patients in Japan. Psychooncology. 2011;20:497–505.
van den Beuken-van Everdingen MHJ, Peters ML, de Rijke JM, Schouten HC, van Kleef M, Patijn J. Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study. Psychooncology. 2008;17:1137–45.
Mishel MH, Germino BB, Gil KM, Belyea M, Laney IC, Stewart J, et al. Benefits from an uncertainty management intervention for African-American and Caucasian older long-term breast cancer survivors. Psycho Oncology. 2005;14:962–78.
Vickberg SMJ. The Concerns About Recurrence Scale (CARS): a systematic measure of women’s fears about the possibility of breast cancer recurrence. Ann Behav Med. 2003;25:16–24.
Akechi T, Momino K, Yamashita T, Fujita T, Hayashi H, Tsunoda N, et al. Contribution of problem-solving skills to fear of recurrence in breast cancer survivors. Breast Cancer Res Treat. 2014;145:205–10.
Momino K, Akechi T, Yamashita T, Fujita T, Hayahi H, Tsunoda N, et al. Psychometric properties of the Japanese version of the concerns about recurrence scale (CARS-J). Jpn J Clin Oncol. 2014;44:456–62.
Akechi T, Momino K, Iwata H. Brief screening of patients with distressing fear of recurrence in breast cancer survivors. Breast Cancer Res Treat. 2015;153:475–6.
Mendoza TR, Chen C, Brugger A, Hubbard R, Snabes M, Palmer SN, et al. Lessons learned from a multiple-dose post-operative analgesic trial. Pain. 2004;109:103–9.
Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330:592–6.
Cleeland CS, Nakamura Y, Mendoza TR, Edwards KR, Douglas J, Serlin RC. Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain. 1996;67:267–73.
Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med. 1994;23:129–38.
Bruce J, Thornton AJ, Powell R, Johnston M, Wells M, Heys SD, et al. Psychological, surgical, and sociodemographic predictors of pain outcomes after breast cancer surgery: a population-based cohort study. Pain. 2014;155:232–43.
van Helmond N, Timmerman H, van Dasselaar NT, van de Pol CC, Olesen SS, Drewes AM, et al. High body mass index is a potential risk factor for persistent postoperative pain after breast cancer treatment. Pain Physician. 2017;20:E661–71.
Manfuku M, Nishigami T, Mibu A, Tanaka K, Kitagaki K, Sumiyoshi K. Comparison of central sensitization-related symptoms and health-related quality of life between breast cancer survivors with and without chronic pain and healthy controls. Breast Cancer. 2019;26:758–65. https://doi.org/10.1007/s12282-019-00979-y.
Roth RS, Qi J, Hamill JB, Kim HM, Ballard TNS, Pusic AL, et al. Is chronic postsurgical pain surgery-induced? A study of persistent postoperative pain following breast reconstruction. Breast. 2018;37:119–25.
Wallace MS, Wallace AM, Lee J, Dobke MK. Pain after breast surgery: a survey of 282 women. Pain. 1996;66:195–205.
Tait RC, Zoberi K, Ferguson M, Levenhagen K, Luebbert RA, Rowland K, et al. Persistent post-mastectomy pain: risk factors and current approaches to treatment. J Pain. 2018;19:1367–83.
Reyad RM, Omran AF, Abbas DN, Kamel MA, Shaker EH, Tharwat J, et al. The possible preventive role of pregabalin in postmastectomy pain syndrome: a double-blinded randomized controlled trial. J Pain Symptom Manage. 2019;57:1–9. https://doi.org/10.1016/j.jpainsymman.2018.10.496.
Tauber NM, O’Toole MS, Dinkel A, Galica J, Humphris G, Lebel S, et al. Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. JCO. 2019;37:2899–915.
Acknowledgements
We are grateful to the patients that participated in this study. We also thank Audrey Holmes, MA, from Edanz Group (https://jp.edanz.com/ac) for editing a draft of this manuscript.
Funding
This research was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Science, and Technology.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Data collection and analysis were performed by all authors. The first draft of the manuscript was written by YU, NK and MU, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Research involving human participants and/or animals
All procedures performed involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments.
Ethical approval
This study protocol (60-19-0031) was approved by the Institutional Review Board of Nagoya City University Graduate School of Medical Sciences.
Informed consent
Written informed consent for this comprehensive research was obtained from all patients involved in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
About this article
Cite this article
Uemoto, Y., Uchida, M., Kondo, N. et al. Predictive factors for patients who need treatment for chronic post-surgical pain (CPSP) after breast cancer surgery. Breast Cancer 28, 1346–1357 (2021). https://doi.org/10.1007/s12282-021-01275-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12282-021-01275-4